Skip to main content

Table 1 Demographic and baseline characteristics of patients and HCPs

From: Perception gaps between patients with ulcerative colitis and healthcare professionals: an online survey

Characteristic

N

775

Male, %

37

Median age, year (SD)

44.6 (15.1)

National patient organization member, %

10

Single, no partner

25

Single, with partner

26

Married

49

Full-time

43

Part-time

16

Chronic back pain

15

Migraine

14

Arthritis

13

Depression

12

Asthma

10

In flare

11

Mildly symptomatic

43

In remission

46

Currently receiving UC therapy, %

76

5-ASA/aminosalicylate

75

Monotherapy

43

Corticosteroids

32

Immune therapy

24

Antibiotics

8

Biological therapy

15

Other

9

Physicians

N

475

Male, %

82

Mean qualification year (SD)

1992 (9.1)

Gastroenterology

82

Internal medicine

18

Lower GI/IBD specialist, %

68

Office

19

Hospital

64

Equal

17

City center

71

Suburban

23

Rural

6

Teaching hospital, %

67

Public

89

Private

11

Mean % of working day devoted to clinical practice (SD)

87.4 (11.2)

Mean number of patients with UC seen in typical month, n (SD)

35.2 (33.0)

N

50

Male, %

8

Mean year of qualification (SD)

1992 (7.5)

Mean year becoming IBD Nurse (SD)

2003 (3.8)

Nurse practitioner

10

Nurse prescriber

6

Clinical nurse specialist

84

City center

56

Suburban

40

Rural

4

Teaching hospital, %

80

Mean % of working day devoted to direct patient care (SD)

80.8 (14.1)

Mean number of patients with UC seen in typical month, n (SD)

66.6 (40.2)

Percentage of nurses who make treatment decisions for patients with UC

86

Percentage of nurses who are qualified nurse prescriber

44

Percentage of nurses who write 5-ASA prescriptions for mild-to-moderate UC

77

Mean number of 5-ASA prescriptions written per month (SD)

21.4 (15.9)

  1. HCP, healthcare professional; SD, standard deviation; UC, ulcerative colitis; 5-ASA, 5-aminosalicylic acid; GI, gastrointestinal; IBD, inflammatory bowel disease.
  2. *All patients currently taking prescription medication for their UC.
  3. Immunomodulator or immunosuppressant.